Company Description
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally.
The company operates through two reportable segments, Life Sciences Products and Life Sciences Services.
The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows.
The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development.
This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services.
It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes.
The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021.
Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
| Country | United States |
| IPO Date | Feb 2, 1995 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 3,300 |
| CEO | John P. Marotta |
Contact Details
Address: 15 Elizabeth Drive Chelmsford, Massachusetts United States | |
| Website | https://www.azenta.com |
Stock Details
| Ticker Symbol | AZTA |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0000933974 |
| CUSIP Number | 114340102 |
| ISIN Number | US1143401024 |
| Employer ID | 04-3040660 |
| SIC Code | 3559 |
Key Executives
| Name | Position |
|---|---|
| John P. Marotta | President, Chief Executive Officer & Director |
| Lawrence Y. Lin | Executive Vice President & Chief Financial Officer |
| Dr. Ginger Zhou Ph.D. | Senior Vice President and GM of the Genewiz Multiomics & Synthesis Solutions |
| J. Robert Woodward | Senior Vice President of Global Quality & Regulatory |
| Jason W. Joseph J.D. | Senior Vice President, General Counsel & Corporate Secretary |
| John E. O'Brien | Senior Vice President of Corporate Development |
| Michael Paulo | Vice President and Chief Information & Digital Officer |
| Olga Pirogova | Senior Vice President & Chief HR Officer |
| Violetta Hughes | Vice President & Chief Accounting Officer |
| Yvonne Perron | Vice President of Financial Planning & Analysis and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 09, 2024 | 4 | Filing |
| Dec 06, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Dec 05, 2024 | 4 | Filing |
| Dec 02, 2024 | 3 | Filing |
| Nov 27, 2024 | 10-K | Annual Report |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |
| Nov 21, 2024 | 4 | Filing |